Guinea-Bissau vs Iran: Trading across borders: Time to export (days) (DB06-15 methodology)
Guinea-Bissau
60.42
in 2014
Iran
60.42
in 2014
Guinea-Bissau rank
135th
Iran rank
135th
Trading across borders: Time to export (days) (DB06-15 methodology) over time
- Guinea-Bissau
- Iran
How they compare
Guinea-Bissau currently reports 60.42 against 60.42 in Iran, a difference of 0.
Across all 10 years both countries report, Iran has been ahead every year.
Guinea-Bissau ranks 135th and Iran ranks 135th of 183 countries.
Iran has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 57.08 | 58.75 | 1.67 | Iran |
| 2010s | 60.42 | 60.42 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher trading across borders: time to export (days) (db06-15 methodology), Guinea-Bissau or Iran?
- Guinea-Bissau, at 60.42 against 60.42 in Iran as of 2014.
- What is the difference in trading across borders: time to export (days) (db06-15 methodology) between Guinea-Bissau and Iran?
- 0, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Iran?
- 10 years are reported by both, from 2005 to 2014.
- How do Guinea-Bissau and Iran rank globally for trading across borders: time to export (days) (db06-15 methodology)?
- Guinea-Bissau ranks 135th and Iran ranks 135th of 183 countries.
- Where does this data come from?
- The World Bank, published as Trading across borders: Time to export (days) (DB06-15 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for the time to export benchmarks economies with respect to the regulatory best practice on the indicator. The score ranges from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-15 studies.